INTRODUCTION
Focal eosinophilic infiltration in the liver is related to various eosinophil-related conditions and is incidentally found on ultrasonography (US) or computed tomography (CT). The imaging findings of focal lesions are relatively well known, but it is often difficult to differentiate metastasis in patients with malignancy history (1, 2) .
Sonazoid (perfluorobutane; Daiichi-Sankyo, GE, Tokyo, Japan) is a third-generation contrast agent that enables low mechanical index, continuous real-time imaging, and Kupffer imaging. It shows rapid enhancement of the vascular pool after intravenous injection and can be phagocytosed by Kupffer cells in the Kupffer phase (3).
To our knowledge, sonographic findings of eosinophilic liver infiltration using Sonazoid have not been reported in the English literature. Here, we report two cases of sonographic findings of focal eosinophilic infiltration in the liver using Sonazoid.
CASE REPORT

Case 1
A 63-year-old male patient with lung cancer underwent dynamic contrast-enhanced abdominal CT for distant metastasis evaluation. He had no specific symptoms, such as abdominal pain, fever, fatigue, etc. The dynamic contrast-contrast enhanced CT scan showed a 1.4 cm low-attenuation lesion at S5 of the liver on dynamic portal phase CT scan (Fig. 1A) . For metastasis evaluation, the clinician determined a US-guided percutaneous gun biopsy. Examination was performed using an IU-22 (Philips Medical Systems, Bothell, WA, USA) equipped with a 3-5
MHz convex-array transducer. B-mode US revealed an ill-defined low echoic lesion on S5 of the liver (Fig. 1B) Focal eosinophilic infiltration in the liver is often associated with various eosinophilrelated conditions. Focal eosinophilic infiltration in the liver is often identified incidentally by radiologic examinations ordered for other reasons, and is usually visualized radiographically as small, ill-defined, oval or round nodules. Focal eosinophilic infiltration in the liver may sometimes mimic hepatic metastases in those patients who present with a history of malignancy. Here, we present two cases of contrast enhanced ultrasonography findings of focal hepatic eosinophilic infiltration using Sonazoid (perfluorobutane; Daiichi-Sankyo, GE, Tokyo, Japan). phils. Contrast-enhanced abdominal CT was performed and showed a 1.7 cm low-attenuation lesion on S8 of the liver ( Fig.   2A ). The clinician determined US-guided percutaneous gun biopsy for histologic evaluation. B-mode US revealed an ill-defined slight low echoic lesion on S8 of the liver (Fig. 2A) . CEUS demonstrated hypo-enhancement on the 10 minute Kupffer phase ( Fig. 2A) . Eosinophilic infiltration was pathologically diagnosed (Fig. 2B) , and the patient's eosinophil was elevated to 11.8%.
Index terms
DISCUSSION
Eosinophilic infiltration in the liver histologically includes eosinophilic infiltrations in the periportal space, eosinophilic abscess, and eosinophilic granuloma. Eosinophilic infiltration in the liver is often associated with various eosinophil-related conditions, such as parasitic infestation, allergic reactions, hypereosinophilic syndrome, and internal malignancies including lymphoma, leukemia, and cancer of the lung, stomach, pancreas, or ovary. In two cases, the etiology was uncertain through clinical and patient information, except lung cancer history. It is almost usually correlated with eosinophilia (defined as 500 eosinophils/μL in the peripheral blood) and is incidentally discovered on radiologic examinations, such as US or CT.
The imaging findings of focal eosinophilic infiltration in the liver are well known and morphologic findings are similar in US, CT and magnetic resonance image (MRI). At CT, characteristically portal phase of dynamic enhanced study reveals conspicuously multiple, small, round or oval, low attenuated nodular lesions with fuzzy margins in the liver (2, 4, 5). On MRI, these lesions are iso-or slightly low signal intensity on T1 weighted images and have high signal intensity on T2 weighted images. Dynamic MRI more easily demonstrates lesion enhancement on the arterial phase than does dynamic CT (5, 6). On era of hepatobiliary MRI contrast agent, one study using gadobenate dimeglumine-enhanced MRI revealed that the hepatic focal eosinophilic infiltration showed intermingled low signal intensity and isosignal intensity (67%) and homogenous low signal intensity (24%) on hepatobiliary phase. Another study using gadoxetic acid-enhanced MRI revealed that all hepatic focal eosinophilic infiltration lesions showed mixed hypointensity, irregular margins and nonspherical shapes on hepatobiliary phase (7, 8) . 
